Bedminster-based Zelis, a claims cost and payments optimization platform with proprietary technology and solutions to price, pay and explain healthcare claims, announced that R. Andrew Eckert has joined the company as its new chief executive officer. A 30-year veteran of the healthcare technology industry, Eckert has had a lifelong focus on enabling healthcare innovation and leading strong teams to their full potential.
During his career, Eckert has served as CEO of some of the healthcare industry’s most notable and impactful healthcare technology companies, including TriZetto Corporation, Eclipsys Corporation, and Valence Health. In each case, Eckert helped deliver client success, product and technology innovation and strong growth. Immediately prior to joining Zelis, Eckert was the CEO of Acelity, a global advanced wound care company which was sold to 3M in October 2019. Earlier in his career, Eckert served as CEO of CRC Health Group, a leading behavioral health provider owned by Bain Capital, and SumTotal Systems, a leading education technology software company.
Eckert serves on the board of directors of Becton Dickinson, a medical technology company, and as chair of the board of directors of Varian Medical Systems, a radiation oncology treatments and software company.
“Zelis’ mission is to optimize the healthcare payments cycle – which we define as pricing, paying and explaining the claim – on behalf of payors, providers and consumers. Andy’s deep experience leading multiple companies that serve Zelis’ core constituencies, combined with his track record of driving outstanding client success, makes him a terrific choice to lead Zelis going forward,” said Dave Ament, Managing Partner of Parthenon Capital.
“I am delighted that Andy is joining Zelis,” said Devin O’Reilly, managing director, Bain Capital. “Andy is a highly seasoned CEO and he will help position the company to grow, innovate, and transform our industry.”
“I’m thrilled to be joining Zelis. We are a heavyweight in healthcare technology and are at the epicenter of solving some of the industry’s most intractable challenges. I believe our company will continue to make a huge impact in making the U.S. healthcare system more understandable and affordable,” said Eckert. “I look forward to further building and strengthening the company’s momentum in serving our clients with innovative solutions.”
To access more business news, visit NJB News Now.Related Articles: